ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0892
0,00%
Bitcoin
61.544,76
0,58%
Brent Oil
83,725
0,20%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Syneron Medical Ltd. - Ordinary Shares (ELOS)

  7. Syneron Medical Ltd. - Ordinary Shares (ELOS) Notícias

ELOS

Syneron Medical Ltd. - Ordinary Shares (ELOS)

Syneron Medical Ltd. - Ordinary Shares
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ELOS
DataHoraFonteTítuloCódigoCompanhia
01/08/201710:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/07/201710:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201711:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201709:51Edgar (US Regulatory)(25-NSE)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201708:46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201708:30PR Newswire (US)Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanyNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/07/201712:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/06/201710:22PR Newswire (US)Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax PartnersNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/05/201709:37Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/05/201718:00PR Newswire (US)Syneron Medical Reports First Quarter 2017 Revenue of $66.9 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201707:13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201707:00PR Newswire (US)Syneron Candela Announces End of Go-Shop PeriodNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
03/04/201713:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/03/201705:00PR Newswire (US)Syneron Candela Announces CE Mark for CO2RE® IntimaNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201717:10PR Newswire (US)Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its WebsiteNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201716:43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
20/03/201717:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
01/03/201717:05PR Newswire (US)Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual MeetingNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/02/201710:00PR Newswire (US)Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
13/02/201712:00PR Newswire (US)Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare ConferenceNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/02/201712:00GlobeNewswire Inc.Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of DirectorsNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
31/01/201719:05PR Newswire (US)Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources OfficerNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
30/01/201712:00PR Newswire (US)Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
11/11/201619:00PR Newswire (US)Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics ForumNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
09/11/201610:00PR Newswire (US)Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/11/201612:00PR Newswire (US)Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term...NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201617:09Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201609:00PR Newswire (US)Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 RevenueNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/09/201617:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
04/08/201608:00PR Newswire (US)Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
 Apresentando as notícias mais relevantes sobre:NASDAQ:ELOS

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
IBOV
Índice Bovespa
BOV
VVEO3
CM Hospitalar ON
BOV
JHSF3
JHSF PART ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
SGPS3
SPRINGS ON
BOV
ENAT3
ENAUTA ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PRIO3
PETRORIO ON
BOV
BRKM5
BRASKEM PNA
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados